The ongoing mission of the NIAAA-funded Consortium to improve OutcoMes in hiv/Aids, Alcohol, Aging, and multi-Substance use (COMpAAAS) is to build and disseminate the evidence needed to optimize care for HIV+ individuals experiencing medical harm from alcohol and related substance use through coordinated, integrated, and externally validated observational, OR modeling, and intervention studies. Over the past 5 years, we have coordinated two meetings of the entire CHAART consortia (a third scheduled February 2016) and successfully conducted coordinated observational research, operations research (OR) modeling and intervention studies focused on the role of alcohol and multisubstance use in determining modifiable outcomes among HIV+ and uninfected individuals. Our highly effective Coordinating Center at the West Haven VA Medical Center has facilitated the expansion of our productive network of investigators and collaborators. Over the past 15 years, our group has produced >250 publications and these were cited >1,700 times in 2014. Our work has directly influenced VA and national guideline development and has provided essential insights into HIV, aging and alcohol and multisubstance use. We are proud of the education, training, and career development support we offer. COMpAAAS goals for the next 5 years build on our prior work and include: developing unbiased estimates of the effect of polypharmacy, potentially inappropriate medications (PIMs), alcohol use, and treatment for Alcohol Use Disorder (AUD) and hepatitis C (HCV) to inform simplification and prioritization of pharmaceutical treatment (COMpAAAS U01: Observational Study); expanding our alcohol intervention studies using contingency management and addressing the interaction between alcohol use and medical conditions (COMpAAAS U01: Intervention Study); and use Operations Research modeling to understand the implications of various approaches to screening for alcohol use prior to HCV treatment (COMpAAAS U01: OR Modeling Study). Drawing on prior experience, our extensive network of investigators, collaborators, trainees, policy makers, and patients, this U24 proposal (COMpAAAS U24: Coordinating Center) will coordinate, support, and inform the 3 U01 projects and 2 U24 Resource Centers (COMpAAAS U24: RIB and COMpAAAS U24: CHAMP) with resources, information, technologies, ideas, and expertise to greatly enhance their impact.

Public Health Relevance

The ongoing mission of the NIAAA-funded Consortium to improve OutcoMes in hiv/Aids, Alcohol, Aging, and multi-Substance use (COMpAAAS) is to build and disseminate the evidence needed to optimize care for HIV+ individuals experiencing medical harm from alcohol and related substance use through coordinated, integrated, and externally validated research. This proposal describes operations of the West Haven Coordinating Center.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
2U24AA020794-06
Application #
9205931
Study Section
Special Emphasis Panel (ZAA1-DD (10)V)
Program Officer
Roach, Deidra
Project Start
2011-09-10
Project End
2021-08-31
Budget Start
2016-09-10
Budget End
2017-08-31
Support Year
6
Fiscal Year
2016
Total Cost
$235,620
Indirect Cost
$55,620
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Williams, Emily C; McGinnis, Kathleen A; Bobb, Jennifer F et al. (2018) Changes in alcohol use associated with changes in HIV disease severity over time: A national longitudinal study in the Veterans Aging Cohort. Drug Alcohol Depend 189:21-29
Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504
Halpin, Sean N; Carruth, Edwin Clayton; Rai, Ramona P et al. (2018) Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment. AIDS Behav 22:848-852
Matson, Theresa E; McGinnis, Kathleen A; Rubinsky, Anna D et al. (2018) Gender and alcohol use: influences on HIV care continuum in a national cohort of patients with HIV. AIDS 32:2247-2253
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Barry, Declan T; Marshall, Brandon D L; Becker, William C et al. (2018) Duration of opioid prescriptions predicts incident nonmedical use of prescription opioids among U.S. veterans receiving medical care. Drug Alcohol Depend 191:348-354
Beckman, Joshua A; Duncan, Meredith S; Alcorn, Charles W et al. (2018) Association of Human Immunodeficiency Virus Infection and Risk of Peripheral Artery Disease. Circulation 138:255-265
Justice, Amy C; Gordon, Kirsha S; Skanderson, Melissa et al. (2018) Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals. AIDS 32:739-749
Eyawo, Oghenowede; McGinnis, Kathleen A; Justice, Amy C et al. (2018) Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected. J Acquir Immune Defic Syndr 77:135-143
Rentsch, Christopher T; Cartwright, Emily J; Gandhi, Neel R et al. (2018) Provider verification of electronic health record receipt and nonreceipt of direct-acting antivirals for the treatment of hepatitis C virus infection. Ann Epidemiol 28:808-811

Showing the most recent 10 out of 133 publications